We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Real-World Evidence has been used to speed access to new treatment options, especially for rare diseases, and served as a resource to better characterize treatment effects, including those in underrepresented populations. In this episode of Industry Voice our guest, Galina Osina, RWE Lead at Roche will help us analyze the ongoing and future trends of Real-World Data in pharmaceutical research.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
